TY - JOUR
T1 - Chronic Pain and Mental Health Disorders
T2 - Shared Neural Mechanisms, Epidemiology, and Treatment
AU - Hooten, W. Michael
N1 - Publisher Copyright:
© 2016 Mayo Foundation for Medical Education and Research
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Chronic pain and mental health disorders are common in the general population, and epidemiological studies suggest that a bidirectional relationship exists between these 2 conditions. The observations from functional imaging studies suggest that this bidirectional relationship is due in part to shared neural mechanisms. In addition to depression, anxiety, and substance use disorders, individuals with chronic pain are at risk of other mental health problems including suicide and cigarette smoking and many have sustained sexual violence. Within the broader biopsychosocial model of pain, the fear-avoidance model explains how behavioral factors affect the temporal course of chronic pain and provides the framework for an array of efficacious behavioral interventions including cognitive-behavioral therapy, acceptance-based therapies, and multidisciplinary pain rehabilitation. Concomitant pain and mental health disorders often complicate pharmacological management, but several drug classes, including serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, and anticonvulsants, have efficacy for both conditions and should be considered first-line treatment agents.
AB - Chronic pain and mental health disorders are common in the general population, and epidemiological studies suggest that a bidirectional relationship exists between these 2 conditions. The observations from functional imaging studies suggest that this bidirectional relationship is due in part to shared neural mechanisms. In addition to depression, anxiety, and substance use disorders, individuals with chronic pain are at risk of other mental health problems including suicide and cigarette smoking and many have sustained sexual violence. Within the broader biopsychosocial model of pain, the fear-avoidance model explains how behavioral factors affect the temporal course of chronic pain and provides the framework for an array of efficacious behavioral interventions including cognitive-behavioral therapy, acceptance-based therapies, and multidisciplinary pain rehabilitation. Concomitant pain and mental health disorders often complicate pharmacological management, but several drug classes, including serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, and anticonvulsants, have efficacy for both conditions and should be considered first-line treatment agents.
UR - http://www.scopus.com/inward/record.url?scp=84991585586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991585586&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2016.04.029
DO - 10.1016/j.mayocp.2016.04.029
M3 - Review article
C2 - 27344405
AN - SCOPUS:84991585586
SN - 0025-6196
VL - 91
SP - 955
EP - 970
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 7
ER -